Eur Rev Med Pharmacol Sci 2021; 25 (2): 572-573
DOI: 10.26355/eurrev_202101_24609

Author Correction: A functional Cis-eQTL locus in lncRNA ZNRD1-AS1 contributes to the susceptibility of endometrial cancer

J.-T. Peng, M.-C. Li

Reproductive Medicine Center, the Sixth Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.


Correction to: European Review for Medical and Pharmacological Sciences 2019; 23 (18): 7802-7807–DOI: 10.26355/eurrev_201909_18989–PMID: 31599404, published online 15 September, 2020.

The authors state that “to compare the results with those of bladder cancer in the literature we reported the study by Li D, Song L, Wen Z, Li X, Jie J, Wang Y, Peng L. Strong evidence for LncRNA ZNRD1-AS1, and its functional Cis- eQTL locus contributing more to the susceptibility of lung cancer. Oncotarget 2016; 7: 35813-35817. In particular, we referred to their table format, but we misused the reference table as the official table in the manuscript”.

In addition to Table I, the authors make the following corrections:

• in the abstract results change “(OR: 1.33; 95% CI: 1.09-1.61; p = 0.004)” to “(OR: 1.31; 95% CI: 1.08-1.6; p=0.007).”

• in the “Association of tagSNPs of the Cis-eQTL for ZNRD1 in ZNRD1-AS1 Gene Region With EC Susceptibility” paragraph change “(OR: 1.33; 95% CI: 1.09-1.61; p = 0.004)” to “(OR: 1.31; 95% CI: 1.08-1.6; p=0.007), “1.71 (95% CI: 1.11-2.64)” to “1.67 (95% CI: 1.07-2.59)”, and “(0.004 × 3 = 0.012 < 0.05)” to “(0.007*3=0.021<0.05)”.

There are amendments to this paper.  The Publisher apologizes for any inconvenience this may cause.

A functional Cis-eQTL locus in lncRNA ZNRD1-AS1 contributes to the susceptibility of endometrial cancer

Free PDF Download

To cite this article

J.-T. Peng, M.-C. Li
Author Correction: A functional Cis-eQTL locus in lncRNA ZNRD1-AS1 contributes to the susceptibility of endometrial cancer

Eur Rev Med Pharmacol Sci
Year: 2021
Vol. 25 - N. 2
Pages: 572-573
DOI: 10.26355/eurrev_202101_24609